Skip to main navigation Skip to search Skip to main content

B014: Collection of Blood Samples, Genotyping, and Disclosure of APOE Genotype Results to Participants From Completed Donanemab or Remternetug Clinical Studies

Project: Research

Project Details

StatusActive
Effective start/end date05/22/26 → 12/31/26

Funding

  • Lilly USA LLC: $6,604.00